Literature DB >> 2241624

Background review and current concepts of reperfusion injury.

J M Hallenbeck1, A J Dutka.   

Abstract

We define the concept of reperfusion injury, and we present a background chronology of experimental work supporting and questioning this concept. We identify several new influences, such as current clinical interest in thrombolytic therapy for acute ischemia of heart and brain and the growing recognition of endothelium as a regulator of homeostasis. We propose that these influences will encourage a reexamination of reperfusion injury as a factor in the ultimate outcome of tissue exposed to reversible ischemia. We briefly discuss the major mechanisms presently implicated in reperfusion injury--loss of calcium homeostasis, free radical generation, leukocyte-mediated injury, and acute hypercholesterolemia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2241624     DOI: 10.1001/archneur.1990.00530110107027

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  32 in total

Review 1.  Current status of neuroprotective agents in the treatment of acute ischemic stroke.

Authors:  H L Lutsep; W M Clark
Journal:  Curr Neurol Neurosci Rep       Date:  2001-01       Impact factor: 5.081

2.  EGCG ameliorates the suppression of long-term potentiation induced by ischemia at the Schaffer collateral-CA1 synapse in the rat.

Authors:  Jie Ding; Gang Fu; Yan Zhao; Zhenyong Cheng; Yang Chen; Bo Zhao; Wei He; Lian-Jun Guo
Journal:  Cell Mol Neurobiol       Date:  2011-11-11       Impact factor: 5.046

3.  Effects of reperfusion on ADC and CBF pixel-by-pixel dynamics in stroke: characterizing tissue fates using quantitative diffusion and perfusion imaging.

Authors:  Qiang Shen; Marc Fisher; Christopher H Sotak; Timothy Q Duong
Journal:  J Cereb Blood Flow Metab       Date:  2004-03       Impact factor: 6.200

4.  Thrombolytic therapy of acute ischemic stroke: correlation of angiographic recanalization with clinical outcome.

Authors:  Osama O Zaidat; Jose I Suarez; Jeffrey L Sunshine; Robert W Tarr; Michael J Alexander; Tony P Smith; David S Enterline; Warren R Selman; Dennis M D Landis
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

5.  Anti-inflammation Effects of Oxysophoridine on Cerebral Ischemia-Reperfusion Injury in Mice.

Authors:  Yong-Sheng Wang; Yu-Xiang Li; Peng Zhao; Hong-Bo Wang; Ru Zhou; Yin-Ju Hao; Jie Wang; Shu-Jing Wang; Juan Du; Lin Ma; Tao Sun; Jian-Qiang Yu
Journal:  Inflammation       Date:  2015-12       Impact factor: 4.092

6.  Reperfusion after ischemic stroke is associated with reduced brain edema.

Authors:  Hannah J Irvine; Ann-Christin Ostwaldt; Matthew B Bevers; Simone Dixon; Thomas Wk Battey; Bruce Cv Campbell; Stephen M Davis; Geoffrey A Donnan; Kevin N Sheth; Reza Jahan; Jeffrey L Saver; Chelsea S Kidwell; W Taylor Kimberly
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-21       Impact factor: 6.200

7.  The Impact of Histological Clot Composition in Embolic Stroke.

Authors:  T Boeckh-Behrens; M Schubert; A Förschler; S Prothmann; K Kreiser; C Zimmer; J Riegger; J Bauer; F Neff; V Kehl; J Pelisek; L Schirmer; M Mehr; H Poppert
Journal:  Clin Neuroradiol       Date:  2014-09-27       Impact factor: 3.649

8.  Short period of early reperfusion aggravates blood-brain barrier dysfunction during permanent focal ischemia in rats.

Authors:  Johannes Woitzik; Axel Hohenstein; Nils Hecht; Eric Juettler; Lothar Schilling
Journal:  Transl Stroke Res       Date:  2010-09-04       Impact factor: 6.829

9.  Leukocyte-endothelial interactions in pial arterioles and venules on development of cerebral ischemia in rats.

Authors:  N N Mel'nikova
Journal:  Neurosci Behav Physiol       Date:  2009-01-13

10.  Selective brain cooling with endovascular intracarotid infusion of cold saline: a pilot feasibility study.

Authors:  J H Choi; R S Marshall; M A Neimark; A A Konstas; E Lin; Y T Chiang; H Mast; T Rundek; J P Mohr; J Pile-Spellman
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-06       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.